Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • narain
    Banned
    • Aug 2011
    • 73

    Contigs Vs Scaffolds for Assembly Analysis

    Hi Members

    I am using Assembly tools to generate contigs and scaffolds. One tool gives contigs with higher N50 than another tool. The same tool however gives scaffolds with lower N50 than the other tool. Should I use contigs or the scaffolds to conduct analysis such as comparing with the reference genome ? Scaffolds are essentially set of contigs with estimates of gaps in between which are represented by Ns.

    Aby
  • tonybolger
    Senior Member
    • Feb 2010
    • 156

    #2
    Originally posted by narain View Post
    I am using Assembly tools to generate contigs and scaffolds. One tool gives contigs with higher N50 than another tool. The same tool however gives scaffolds with lower N50 than the other tool. Should I use contigs or the scaffolds to conduct analysis such as comparing with the reference genome ?
    Scaffolds, if you can. Not all tools work well with long N stretches though.

    Comment

    • narain
      Banned
      • Aug 2011
      • 73

      #3
      Hi Tony

      Thank you for your suggestion for using scaffolds. But the question reduces further to scafoold from which tool will be more sensible.

      As I said earlier, the scaffolds generated by 1st tool have less N50 than the scaffolds generated by 2nd tool. However, the contigs in the scaffolds of the 1st tool have higher N50 thank the contigs in the scaffolds by 2nd tool. Does this not mean that the higher N50 in the scaffolds generated by 2nd tool is all attributed to more N's in between, and thus the scaffolds of the 2nd tool are not as reliable as the scaffolds of the 1st tool, though the second tools scaffolds have higher N50 ?

      Aby

      Comment

      • tonybolger
        Senior Member
        • Feb 2010
        • 156

        #4
        Originally posted by narain View Post
        Thank you for your suggestion for using scaffolds. But the question reduces further to scafoold from which tool will be more sensible.

        As I said earlier, the scaffolds generated by 1st tool have less N50 than the scaffolds generated by 2nd tool. However, the contigs in the scaffolds of the 1st tool have higher N50 thank the contigs in the scaffolds by 2nd tool. Does this not mean that the higher N50 in the scaffolds generated by 2nd tool is all attributed to more N's in between, and thus the scaffolds of the 2nd tool are not as reliable as the scaffolds of the 1st tool, though the second tools scaffolds have higher N50 ?
        I would compare the two sets of scaffolds. You need to make a combined judgement based on N50/total size and other factors, such as how well the assembled sequences seem to match some reference or part thereof.

        N50 isn't really a definitive measure of quality - it can just indicate that one tool is taking more risks than the other, which considers a particular joining as insufficiently supported. You can get a wonderful N50 by just concatenating all the reads - it's not likely to be correct though.

        I wouldn't really worry about the contig vs scaffold size strangeness - some tools apply some approaches or data later than others. For example, SOAPdenovo doesn't seem to use pairing information at all at the contig stage, so its contigs are always relatively small vs alternatives which do use pairing, but on the other hand, it maintains a full graph for scaffolding, so it works much better with its own contigs than an imported set.

        Comment

        • narain
          Banned
          • Aug 2011
          • 73

          #5
          Hi Tony

          Thank you for suggestion. It looks quite tedious task to compare the quality of the assembly then if not just a parameter such as N50. Thanks for those inputs though I feel the N50 which has been fairly established since many years should also be kept as one of the prominent criteria to judge. I wasn't naming the tools intentionally as then members will get biased in their replies and comments.

          Aby

          Comment

          • tonybolger
            Senior Member
            • Feb 2010
            • 156

            #6
            Originally posted by narain View Post
            Thank you for suggestion. It looks quite tedious task to compare the quality of the assembly then if not just a parameter such as N50.
            Agreed. There are some quality checking approaches out there (e.g. from AMOS) which give some numbers - not sure if they'll scale to your dataset.

            Originally posted by narain View Post
            Thanks for those inputs though I feel the N50 which has been fairly established since many years should also be kept as one of the prominent criteria to judge.
            I agree - though N50 must be combined with total size or % completeness. Otherwise you can just game the N50 by dropping all of the short contigs/scaffolds.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Today, 12:17 PM
            0 responses
            10 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, Yesterday, 11:41 AM
            0 responses
            11 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            37 views
            0 reactions
            Last Post SEQadmin2  
            Working...